Graf Akcie CVS (CVS Health Corp). Diskuze k akciím CVS. Aktuální informace CVS.

Základní informace o společnosti CVS Health Corp (Akcie CVS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 110.96B
Hodnota podniku (EV) 159.98B
Tržby 278.323B
EBITDA 18.192B
Zisk 7.203B
Růst v tržbách Q/Q 11.13 %
Růst v tržbách Y/Y 5.51 %
P/E (Cena vůči ziskům) 15.69
Forward P/E 4.30
EV/Sales 0.57
EV/EBITDA 8.79
EV/EBIT 12.88
PEG 1.87
Price/Sales 0.40
P/FCF 9.55
Price/Book 1.60
Účetní hodnota na akcii 53.68
Hotovost na akcii 8.40
FCF vůči ceně 10.47 %
Počet zaměstnanců 2,020
Tržba na zaměstnance 137784000
Profit margin 2.67 %
Operating margin 4.91 %
Gross margin 18.25 %
EBIT margin 4.46 %
EBITDA margin 6.54 %
EPS - Zisk na akcii 5.47
EPS - Kvartální růst -8.33 %
EPS - Očekávaný růst příští rok 6.63 %
Return on assets 3.12 %
Return on equity 10.21 %
ROIC 5.59 %
ROCE 7.23 %
Dluhy/Equity 2.32
Čistý dluh/EBITDA 16.07
Current ratio 0.95
Quick Ratio 0.67
Volatilita 1.94
Beta 0.63
RSI 56.92
Cílová cena analytiků 82
Známka akcie (dle analytiků) 1.62
Insider ownership 0.18 %
Institutional ownership 78.62 %
Počet akcií 1.32B
Procento shortovaných akcií 1.13 %
Short ratio 3.07 %
Dividenda 2.00
Procentuální dividenda 2.37 %
Dividenda/Zisk 36.56 %
Obchodovaná od 1978
Země United States

Finanční výsledky akcie CVS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$268,706$256,776$194,579$184,786$177,546$153,290
Cost Of Goods Sold$163,981$158,719$156,447$153,448$146,533$126,762
Gross Profit$104,725$98,057$38,132$31,338$31,013$26,528
Research And Development Expenses------
SG&A Expenses------
Other Operating Income Or Expenses$-90,814$-86,070$-27,962$-21,619$-20,627$-17,053
Operating Expenses$254,795$244,789$190,558$175,248$167,160$143,815
Operating Income$13,911$11,987$4,021$9,538$10,386$9,475
Total Non-Operating Income/Expense$-4,141$-2,990$-2,615$-1,270$-1,749$-859
Pre-Tax Income$9,770$8,997$1,406$8,268$8,637$8,616
Income Taxes$2,569$2,366$2,002$1,637$3,317$3,386
Income After Taxes$7,201$6,631$-596$6,631$5,320$5,230
Other Income------
Income From Continuous Operations$7,201$6,631$-596$6,631$5,320$5,230
Income From Discontinued Operations$-9--$-8$-1$9
Net Income$7,179$6,634$-594$6,622$5,317$5,237
EBITDA$18,352$16,358$12,888$12,198$12,861$11,567
EBIT$13,911$11,987$4,021$9,538$10,386$9,475
Basic Shares Outstanding1,3091,3011,0441,0201,0731,118
Shares Outstanding1,3141,3051,0441,0241,0791,126
Basic EPS$5.48$5.10$-0.57$6.47$4.93$4.66
EPS - Earnings Per Share$5.46$5.08$-0.57$6.44$4.90$4.63
# 2020 2019 2018 2017 2016 2015
Current Ratio0.90890.94371.0281.0191.18261.2585
Long-term Debt / Capital0.45930.50210.54960.37040.41020.4138
Debt/Equity Ratio0.92751.06721.25430.71630.74740.7382
Gross Margin38.973838.187819.597216.959117.467617.3058
Operating Margin5.1774.66832.06655.16165.84986.1811
EBIT Margin5.1774.66832.06655.16165.84986.1811
EBITDA Margin6.82986.37056.62356.60127.24387.5458
Pre-Tax Profit Margin3.63593.50380.72264.47444.86475.6207
Net Profit Margin2.67172.5836-0.30533.58362.99473.4164
Asset Turnover1.16471.15430.99041.94241.87961.6583
Inventory Turnover Ratio8.86589.06149.510510.03199.92779.0538
Receiveable Turnover12.358813.089511.036214.019114.59612.8945
Days Sales In Receivables29.533527.88533.07326.035925.006828.3066
ROE - Return On Equity10.331310.3335-1.018117.591214.443214.058
Return On Tangible Equity-17.5664-13.6161.0519-46.0934-35.6425-35.3833
ROA - Return On Assets3.12122.9809-0.30346.97045.63195.6579
ROI - Return On Investment5.58625.1455-0.458511.07468.5198.2401
Book Value Per Share53.206949.285745.20737.174634.716333.7902
Operating Cash Flow Per Share2.22861.35380.6721-1.57921.8150.6228
Free Cash Flow Per Share2.25671.42230.5939-1.3911.82490.3695